Denali Therapeutics Inc. (DNLI)
Market Closed
20 Jul, 20:00
$
22. 90
-0.39
-1.6745%
$
3.63B Market Cap
- P/E Ratio
- Div Yield
1.15M Volume
-1.08 Eps
$ 23.29
Previous Close 
Want to track DNLI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Denali Therapeutics Inc. (DNLI) Statistics
Valuation metrics
Market Cap 3.63B
Enterprise value 3.35B
Trailing P/E (ttm) -8.09
Forward P/E -7.78
PEG ratio 1.04
Price/Sales (ttm) -
Price/Book (mrq) 4.69
Enterprise Value/Revenue -
Enterprise Value/EBITDA -6.79
Overview
Shares outstanding 156.18M
Float 144.36M
Shares short 15.42M
% Held by insiders 0.09%
% Held by institutions 0.98%
Average volume (10 days) 1.32M
Average volume (90 days) 1.9M
Price summary
52-Week low 12.58
52-Week high 27.3
Beta 1.1
50-Day moving average 24.49
200-Day moving average 20.06
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.4%
Return on equity -0.52%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -418.78M
EBITDA -540.53M
Net income to common (ttm) -512.54M
Diluted EPS (ttm) -2.72
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 867.88M
Total cash per share (mrq) 5.29
Total debt (mrq) 42.29M
Total Debt/Equity (mrq) 0.04
Current ratio (mrq) 9.28%
Book value per share (mrq) 4.96
Cash Flow
Cash flow statement -412.6M
Levered free cash flow (LFCF) -244.19M
